Robert Canarick - 03 Nov 2021 Form 4 Insider Report for INTEGRATED BIOPHARMA INC (INBP)

Role
Director
Signature
/s/ Robert Canarick
Issuer symbol
INBP
Transactions as of
03 Nov 2021
Net transactions value
$0
Form type
4
Filing time
03 Nov 2021, 18:46:43 UTC
Next filing
21 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INBP Stock Option (right to buy) Award $0 +50,000 $0.000000 50,000 03 Nov 2021 Common Stock 50,000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Exercise Price of the Stock Option will be the closing prices of the Issuer's Common Stock five trading days after the filing of the Issuer's Quarterly Report on Form 10-Q for the period ended September 30, 2021, with the Securities and Exchange Commission (the "Issue Date").
F2 The option vests and becomes exercisable as follows: 25% (12,500 shares) on the Issue Date, 25% (12,500 shares) on December 31, 2021, 25% (12,500 shares) on March 31, 2022 and 25% (12,500 shares) on June 30, 2022.